In addition to cancers resistant to anti-PD-L1 therapy, cancer growth of MC38 mice, a colorectal cancer model which shows a partial response to anti-PD-L1 therapy, is also suppressed by Rab27A knockout (52). Here, CD274 is linked to cancer.